Sagimet director George Kemble disposes of 20,206 common shares worth $201,160.97

Reuters2026/08/12 23:41

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sagimet Biosciences director George Kemble sold 20,206 shares of Series A Common Stock on Aug. 11, 2026 at USD 9.95.
He exercised stock options for 20,206 shares at USD 6.36 the same day.
Direct holdings fell to 62,161 shares following the transactions.
Remaining stock options totaled 394,050 shares after the exercises.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sagimet Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-347407), on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sagimet director George Kemble disposes of 20,206 common shares worth $201,160.97

You may also like

Crypto prices